GPD1L anticorps (Middle Region)
-
- Antigène Voir toutes GPD1L Anticorps
- GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp GPD1L est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- GPD1 L antibody was raised against the middle region of GPD1
- Purification
- Affinity purified
- Immunogène
- GPD1 L antibody was raised using the middle region of GPD1 corresponding to a region with amino acids ELEKEMLNGQKLQGPQTSAEVYRILKQKGLLDKFPLFTAVYQICYESRPV
- Top Product
- Discover our top product GPD1L Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
GPD1L Blocking Peptide, catalog no. 33R-2538, is also available for use as a blocking control in assays to test for specificity of this GPD1L antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GPD0 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))
- Autre désignation
- GPD1L (GPD1L Produits)
- Synonymes
- anticorps wu:fi13g03, anticorps wu:fi45b08, anticorps zgc:92580, anticorps GPD1-L, anticorps 2210409H23Rik, anticorps D9Ertd660e, anticorps RGD1560123, anticorps glycerol-3-phosphate dehydrogenase 1 like, anticorps glycerol-3-phosphate dehydrogenase 1-like, anticorps glycerol-3-phosphate dehydrogenase 1 like L homeolog, anticorps gpd1l, anticorps GPD1L, anticorps gpd1l.L, anticorps Gpd1l
- Sujet
- GPD1L belongs to the NAD-dependent glycerol-3-phosphate dehydrogenase family. Defects in GPD1L are the cause of Brugada syndrome type 2 (BRS2) and sudden infant death syndrome (SIDS).
- Poids moléculaire
- 38 kDa (MW of target protein)
-